Kanako Kato

1.1k total citations · 1 hit paper
22 papers, 836 citations indexed

About

Kanako Kato is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Kanako Kato has authored 22 papers receiving a total of 836 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 8 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Molecular Biology. Recurrent topics in Kanako Kato's work include Diabetes Treatment and Management (7 papers), Liver Disease Diagnosis and Treatment (4 papers) and Pancreatic function and diabetes (4 papers). Kanako Kato is often cited by papers focused on Diabetes Treatment and Management (7 papers), Liver Disease Diagnosis and Treatment (4 papers) and Pancreatic function and diabetes (4 papers). Kanako Kato collaborates with scholars based in Japan and United States. Kanako Kato's co-authors include Yoshimasa Aso, Teruo Jojima, Toshie Iijima, Yasuo Terayama, Isao Usui, Kunihiro Suzuki, Masanori Shimizu, Junko Takahashi, Fumio Yamashita and Makoto Sasaki and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Endocrinology and Neuroscience Letters.

In The Last Decade

Kanako Kato

20 papers receiving 827 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evaluation of the effects of dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non‐alcoholic fatty liver disease

2018 286 citations Masanori Shimizu, Kunihiro Suzuki et al. Diabetes Obesity and Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kanako Kato Japan	11	372	337	255	173	169	22	836
Masashiro Sugawara Japan	15	160 0.4×	73 0.2×	195 0.8×	227 1.3×	60 0.4×	61	749
K. Tsuda Japan	14	217 0.6×	264 0.8×	120 0.5×	301 1.7×	227 1.3×	32	788
Dan Yang China	14	42 0.1×	140 0.4×	41 0.2×	130 0.8×	147 0.9×	47	603
Ioanna Markaki Sweden	14	204 0.5×	102 0.3×	147 0.6×	172 1.0×	49 0.3×	29	638
R. Eissele Germany	20	562 1.5×	173 0.5×	53 0.2×	419 2.4×	723 4.3×	54	1.5k
Jean‐Marc Guettier United States	11	121 0.3×	74 0.2×	35 0.1×	249 1.4×	153 0.9×	11	485
Ph. Heitz United Kingdom	10	201 0.5×	292 0.9×	94 0.4×	162 0.9×	329 1.9×	14	796
Luigi Albano Italy	16	274 0.7×	169 0.5×	114 0.4×	127 0.7×	118 0.7×	53	655
Andreas Bonz Germany	16	138 0.4×	48 0.1×	17 0.1×	363 2.1×	202 1.2×	34	1.0k
Yanmei Yang China	11	74 0.2×	45 0.1×	97 0.4×	130 0.8×	29 0.2×	28	468

Countries citing papers authored by Kanako Kato

Since Specialization

Citations

This map shows the geographic impact of Kanako Kato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kanako Kato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kanako Kato more than expected).

Fields of papers citing papers by Kanako Kato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kanako Kato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kanako Kato. The network helps show where Kanako Kato may publish in the future.

Co-authorship network of co-authors of Kanako Kato

This figure shows the co-authorship network connecting the top 25 collaborators of Kanako Kato. A scholar is included among the top collaborators of Kanako Kato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kanako Kato. Kanako Kato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kato, Kanako, Teruo Jojima, Takahiko Kogai, et al.. (2024). Diabetes with GLP-1R polymorphism (rs3765467) accompanied by myotonic dystrophy: A case of myotonic dystrophy with p.R131Q polymorphism at the glucagon-like peptide-1 receptor (rs3765467) resulting in marked effects of its agonist, dulaglutide. The American Journal of the Medical Sciences. 369(1). 126–130.

Kimura, Naoto, et al.. (2022). Fatal Cerebral Venous Thrombosis in a Pregnant Woman with Inherited Antithrombin Deficiency after BNT162b2 mRNA COVID-19 Vaccination. The Tohoku Journal of Experimental Medicine. 258(4). 327–332. 3 indexed citations

Tanimoto, Yoko, et al.. (2022). Zygote Microinjection for Creating Gene Cassette Knock-in and Flox Alleles in Mice. Journal of Visualized Experiments. 6 indexed citations

Tanimoto, Yoko, et al.. (2022). Zygote Microinjection for Creating Gene Cassette Knock-in and Flox Alleles in Mice. Journal of Visualized Experiments. 3 indexed citations

Sagara, Masaaki, Toshie Iijima, Kanako Kato, et al.. (2021). Serum levels of soluble dipeptidyl peptidase-4 in type 2 diabetes are associated with severity of liver fibrosis evaluated by transient elastography (FibroScan) and the FAST (FibroScan-AST) score, a novel index of non-alcoholic steatohepatitis with significant fibrosis. Journal of Diabetes and its Complications. 35(5). 107885–107885. 10 indexed citations

Aso, Yoshimasa, Masaaki Sagara, Kanako Kato, et al.. (2021). Serum high-molecular-weight adiponectin and response to dapagliflozin in patients with type 2 diabetes and non-alcoholic fatty liver disease. Journal of Investigative Medicine. 69(7). 1324–1329. 9 indexed citations

Jojima, Teruo, Takahiko Kogai, Toshie Iijima, et al.. (2020). A case of hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome with a novel frameshift variant in GATA3, p.W10Cfs40, lacks kidney malformation. SHILAP Revista de lepidopterología. 8(12). 2619–2624. 3 indexed citations

Jojima, Teruo, Takahiko Kogai, Toshie Iijima, et al.. (2020). Genetic alteration of ARMC5 in a patient diagnosed with meningioma and primary macronodular adrenal hyperplasia: a case report. European Journal of Endocrinology. 183(6). K7–K12. 13 indexed citations

Maeda, Tetsuya, et al.. (2019). Impaired metabolism of kynurenine and its metabolites in CSF of parkinson’s disease. Neuroscience Letters. 714. 134576–134576. 42 indexed citations

10.

Aso, Yoshimasa, Kanako Kato, Shintaro Sakurai, et al.. (2019). Impact of dapagliflozin, an SGLT2 inhibitor, on serum levels of soluble dipeptidyl peptidase‐4 in patients with type 2 diabetes and non‐alcoholic fatty liver disease. International Journal of Clinical Practice. 73(5). e13335–e13335. 77 indexed citations

11.

Shimizu, Masanori, Kunihiro Suzuki, Kanako Kato, et al.. (2018). Evaluation of the effects of dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non‐alcoholic fatty liver disease. Diabetes Obesity and Metabolism. 21(2). 285–292. 286 indexed citations breakdown →

12.

Suzuki, Kunihiro, Chie Aoki, Kanako Kato, et al.. (2017). Evaluation of a Premixed Insulin Analog Suspension in Japanese People with Type 2 Diabetes and the Clinical Importance of Improved Injection Techniques: A Cross-Sectional Pilot Study. Diabetes Therapy. 8(2). 445–449. 1 indexed citations

13.

Iijima, Toshie, et al.. (2017). Circulating CD4+PD-1+ and CD8+PD-1+ T cells are profoundly decreased at the onset of fulminant type 1 diabetes and are restored by treatment, contrasting with CD4+CD25+FoxP3+ regulatory T cells. Diabetes Research and Clinical Practice. 133. 10–12. 14 indexed citations

14.

Suzuki, Kunihiro, Seiichi Tanaka, Chie Aoki, et al.. (2014). Greater Efficacy and Improved Endothelial Dysfunction in Untreated Type 2 Diabetes with Liraglutide versus Sitagliptin. 41(3). 211–220. 8 indexed citations

15.

Tanaka, Seiichi, et al.. (2014). Add-On Treatment with Teneligliptin Ameliorates Glucose Fluctuations and Improves Glycemic Control Index in Japanese Patients with Type 2 Diabetes on Insulin Therapy. Diabetes Technology & Therapeutics. 16(12). 840–845. 23 indexed citations

16.

Ohtsuka, Chigumi, Makoto Sasaki, Kanako Kato, et al.. (2014). Differentiation of early-stage parkinsonisms using neuromelanin-sensitive magnetic resonance imaging. Parkinsonism & Related Disorders. 20(7). 755–760. 122 indexed citations

17.

Aso, Yoshimasa, Kanako Kato, Teruo Jojima, et al.. (2013). The serum level of soluble CD26/dipeptidyl peptidase 4 increases in response to acute hyperglycemia after an oral glucose load in healthy subjects: association with high-molecular weight adiponectin and hepatic enzymes. Translational research. 162(5). 309–316. 21 indexed citations

18.

Ohtsuka, Chigumi, Makoto Sasaki, Kanako Kato, et al.. (2013). Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging. Neuroscience Letters. 541. 93–98. 140 indexed citations

19.

Nakamura, Yutaka, Naomi Suzuki, Yoshio Nakajima, et al.. (2013). Scedosporium aurantiacum brain abscess after near-drowning in a survivor of a tsunami in Japan. Respiratory Investigation. 51(4). 207–211. 35 indexed citations

20.

Kato, Kanako, et al.. (2010). Amino Group PEGylation of Bovine Lactoferrin by Linear Polyethylene Glycol-p-nitrophenyl Active Esters. Biological and Pharmaceutical Bulletin. 33(7). 1253–1255. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact